Cargando…
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer’s Disease
[Image: see text] Alzheimer’s disease (AD), the most common type of dementia, currently represents an extremely challenging and unmet medical need worldwide. Amyloid-β (Aβ) and Tau proteins are prototypical AD hallmarks, as well as validated drug targets. Accumulating evidence now suggests that they...
Autores principales: | Gandini, Annachiara, Gonçalves, Ana Elisa, Strocchi, Silvia, Albertini, Claudia, Janočková, Jana, Tramarin, Anna, Grifoni, Daniela, Poeta, Eleonora, Soukup, Ondrej, Muñoz-Torrero, Diego, Monti, Barbara, Sabaté, Raimon, Bartolini, Manuela, Legname, Giuseppe, Bolognesi, Maria Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732823/ https://www.ncbi.nlm.nih.gov/pubmed/36445009 http://dx.doi.org/10.1021/acschemneuro.2c00357 |
Ejemplares similares
-
From Combinations to Single-Molecule Polypharmacology—Cromolyn-Ibuprofen Conjugates for Alzheimer’s Disease
por: Albertini, Claudia, et al.
Publicado: (2021) -
Ultra rapid in vivo screening for anti-Alzheimer anti-amyloid drugs
por: Espargaró, Alba, et al.
Publicado: (2016) -
Profiling donepezil template into multipotent hybrids with antioxidant properties
por: Mezeiova, Eva, et al.
Publicado: (2018) -
Investigation of New Orexin 2 Receptor Modulators Using In Silico and In Vitro Methods
por: Janockova, Jana, et al.
Publicado: (2018) -
Privileged multi-target directed propargyl-tacrines combining cholinesterase and monoamine oxidase inhibition activities
por: Chrienova, Zofia, et al.
Publicado: (2022)